Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
Over the past few months, health systems worldwide have been put to the test with the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though the leading clinical manifestations of the SARS-CoV-2 infection involve the respirato...
Saved in:
| Main Authors: | Rocco A Montone, Giulia Iannaccone, Maria Chiara Meucci, Filippo Gurgoglione, Giampaolo Niccoli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-06-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2020.22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What is New from the 2024 European Society of Cardiology Congress on the Management of Chronic Coronary Syndromes? Updated Guidelines and Trials
by: Filippo Luca Gurgoglione, et al.
Published: (2024-11-01) -
Mechanisms of Myocardial Injury in Coronavirus Disease 2019
by: Aniket S Rali, et al.
Published: (2020-05-01) -
Coronary Microvascular Dysfunction: Insights on Prognosis and Future Perspectives
by: Filippo Luca Gurgoglione, et al.
Published: (2025-01-01) -
Myocardial injury mimicking acute myocardial infarction due to coronavirus infection in adults with pre-existing apical hypertrophic cardiomyopathy
by: Radityo Bagus Wicaksono, et al.
Published: (2024-07-01) -
Lung microbiota of patients with ARDS due to coronavirus disease 2019 receiving ECMO
by: Yumi Mitsuyama, et al.
Published: (2025-07-01)